Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Apperley

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Hematology|November 16, 2020
Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendationsElisabetta Abruzzese, Michael Mauro, Jane Apperley, et al.
Lancet (London, England)|March 19, 2002
Survival after bone-marrow transplantationKate Cwynarski, Charles Craddock, Mark Cobbold, et al.
Blood|June 6, 2003
Monitoring CML after nonmyeloablative transplantations: how negative is negative?Jaspal Kaeda, Jane Apperley, Junia Melo, et al.
American Journal of Hematology|January 26, 2011
Bone marrow trephine biopsy findings in B acute lymphoblastic leukaemia of early precursor (Pro-B) subtypeHeike Schwarb, Philippa C May, Jane Apperley, et al.
Lancet (London, England)|April 15, 2004
Interactive web-based guidelines for chronic myeloid leukaemiaDavid Marin, Amin Rahemtulla, Eduardo Olavarria, et al.
Lancet (London, England)|July 18, 2003
Imatinib or transplant for chronic myeloid leukaemia?John Goldman, Jane Apperley, Edward Kanfer, et al.
Leukemia & Lymphoma|June 25, 2019
The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patientsGeorge Nesr, Simone Claudiani, Jamshid Khorashad, et al.
Croatian Medical Journal|December 4, 2004
Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity surveyAlois Gratwohl, Helen Baldomero, Boris Labar, et al.
Haematologica|April 26, 2012
Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapyPratap Neelakantan, David Marin, Mike Laffan, et al.
Haematologica|December 3, 2011
Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformationDragana Milojkovic, Amr Ibrahim, Alistair Reid, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Hematology|November 16, 2020
Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendationsElisabetta Abruzzese, Michael Mauro, Jane Apperley, et al.
Lancet (London, England)|March 19, 2002
Survival after bone-marrow transplantationKate Cwynarski, Charles Craddock, Mark Cobbold, et al.
Blood|June 6, 2003
Monitoring CML after nonmyeloablative transplantations: how negative is negative?Jaspal Kaeda, Jane Apperley, Junia Melo, et al.
American Journal of Hematology|January 26, 2011
Bone marrow trephine biopsy findings in B acute lymphoblastic leukaemia of early precursor (Pro-B) subtypeHeike Schwarb, Philippa C May, Jane Apperley, et al.
Lancet (London, England)|April 15, 2004
Interactive web-based guidelines for chronic myeloid leukaemiaDavid Marin, Amin Rahemtulla, Eduardo Olavarria, et al.
Lancet (London, England)|July 18, 2003
Imatinib or transplant for chronic myeloid leukaemia?John Goldman, Jane Apperley, Edward Kanfer, et al.
Leukemia & Lymphoma|June 25, 2019
The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patientsGeorge Nesr, Simone Claudiani, Jamshid Khorashad, et al.
Croatian Medical Journal|December 4, 2004
Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity surveyAlois Gratwohl, Helen Baldomero, Boris Labar, et al.
Haematologica|April 26, 2012
Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapyPratap Neelakantan, David Marin, Mike Laffan, et al.
Haematologica|December 3, 2011
Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformationDragana Milojkovic, Amr Ibrahim, Alistair Reid, et al.
Pageof 12